Darin J. Weber - 01 Mar 2024 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
SVP of Regulatory Development
Signature
/s/ James Coulston, as Attorney-in-Fact
Issuer symbol
PROK
Transactions as of
01 Mar 2024
Net transactions value
$0
Form type
4
Filing time
05 Mar 2024, 16:12:12 UTC
Previous filing
06 Feb 2024
Next filing
16 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +225,000 $0.000000 225,000 01 Mar 2024 Class A Ordinary Shares 225,000 $1.61 Direct F1
transaction PROK Employee stock option (right to buy) Award $0 +117,264 $0.000000 117,264 01 Mar 2024 Class A Ordinary Shares 117,264 $1.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2024.
F2 The option vests 50% on the 1st anniversary of March 1, 2024 and the remaining 50% vests in substantially equal monthly installments for 12 months thereafter.